세계의 연하곤란 관리 시장 : 제품, 치료법, 유형, 최종 사용자별 예측(2025-2030년)

The Dysphagia Management Market was valued at USD 3.12 billion in 2023, expected to reach USD 3.32 billion in 2024, and is projected to grow at a CAGR of 5.86%, to USD 4.65 billion by 2030.

Dysphagia management encompasses the range of medical and therapeutic practices intended to alleviate swallowing disorders, which can result from neurological conditions, structural abnormalities, or age-related factors. It is an essential component of healthcare, particularly for aging populations and patients with chronic illnesses like stroke, Parkinson's disease, and dementia. The necessity for effective dysphagia management is underscored by its potential to prevent malnutrition, aspiration pneumonia, and associated complications. Applications involve nutritional interventions, such as modified textures in foods and thickened liquids, alongside advanced therapeutic approaches like neuromuscular electrical stimulation and rehabilitation exercises. The end-use scope spans hospitals, clinics, nursing homes, and home healthcare settings, with a significant concentration in geriatric care and neurology departments. Key growth drivers include the increasing prevalence of dysphagia, technological advancements in therapeutic devices, and a growing awareness among healthcare providers and patients. Additionally, regulatory support and reimbursement policies are facilitating market expansion. Emerging opportunities lie in personalized nutrition solutions and telehealth platforms to deliver remote dysphagia assessments and therapies. However, the market faces limitations due to high costs associated with advanced therapies, a lack of skilled professionals, and variations in regulatory frameworks across regions. Innovation potential is immense in the development of cost-effective, user-friendly diagnostic and therapeutic devices, alongside research into biologically-derived thickeners and food textures that enhance patient compliance and satisfaction. Businesses could capitalize on AI-driven tools for precise dysphagia diagnosis and tailored treatment plans. The nature of the dysphagia management market is dynamic, with increasing investment in research and development expected to unlock further growth. Collaborative initiatives among healthcare providers, technology developers, and nutritional experts will be pivotal in addressing ongoing challenges and tapping into new market opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dysphagia Management Market

The Dysphagia Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of dysphagia and other digestive problems
  • Increasing geriatric population and changing lifestyle patterns
  • Growing awareness of dysphagia and the development of dysphagia detection devices
• Market Restraints
  • Discomfort and side effects associated with dysphagia drugs and tubes
• Market Opportunities
  • Innovations in the assessment and treatment of dysphagia
  • Ongoing investments and development of technologies for dysphagia research
• Market Challenges
  • Ethical issues in dysphagia management

Porter's Five Forces: A Strategic Tool for Navigating the Dysphagia Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dysphagia Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dysphagia Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dysphagia Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dysphagia Management Market

A detailed market share analysis in the Dysphagia Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dysphagia Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dysphagia Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dysphagia Management Market

A strategic analysis of the Dysphagia Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dysphagia Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Becton, Dickinson and Company, Bracco Diagnostics Inc., Cipla Limited, Cook Group Incorporated, Danone S.A., Deosen Biochemical (Ordos) Ltd., Dr. Reddy's Laboratories Ltd., Eisia Co.Ltd., F. Hoffmann-La Roche AG, Flavour Creations, Fresenius Kabi AG, Hormel Foods Corporation, Ingredion Incorporated, International Flavors & Fragrances Inc., Johnson & Johnson Services, Inc., Kent Precision Foods Group, Inc., Medline Industries, LP, Nestle S.A., Novartis AG, Phagenesis Ltd., Rosemont Pharmaceuticals Limited, Slo Drinks, and VitalStim UK Ltd..

Market Segmentation & Coverage

This research report categorizes the Dysphagia Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Devices, Drug, and Feeding Tube. The Feeding Tube is further studied across Nutritional Solutions and Proton Pump Inhibitor.
• Based on Treatment & Therapies, market is studied across Esophageal Dysphagia, Oropharyngeal Dysphagia, and Severe Dysphagia.
• Based on Types, market is studied across High (Oropharyngeal) Dysphagia and Low (Esophageal) Dysphagia.
• Based on End User, market is studied across Drug Stores, Hospital Pharmacies, Retail Pharmacies, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of dysphagia and other digestive problems
    • 5.1.1.2. Increasing geriatric population and changing lifestyle patterns
    • 5.1.1.3. Growing awareness of dysphagia and the development of dysphagia detection devices
  • 5.1.2. Restraints
    • 5.1.2.1. Discomfort and side effects associated with dysphagia drugs and tubes
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in the assessment and treatment of dysphagia
    • 5.1.3.2. Ongoing investments and development of technologies for dysphagia research
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical issues in dysphagia management
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Dysphagia Management Market, by Product

• 6.1. Introduction
• 6.2. Devices
• 6.3. Drug
• 6.4. Feeding Tube
  • 6.4.1. Nutritional Solutions
  • 6.4.2. Proton Pump Inhibitor

7. Dysphagia Management Market, by Treatment & Therapies

• 7.1. Introduction
• 7.2. Esophageal Dysphagia
• 7.3. Oropharyngeal Dysphagia
• 7.4. Severe Dysphagia

8. Dysphagia Management Market, by Types

• 8.1. Introduction
• 8.2. High (Oropharyngeal) Dysphagia
• 8.3. Low (Esophageal) Dysphagia

9. Dysphagia Management Market, by End User

• 9.1. Introduction
• 9.2. Drug Stores
• 9.3. Hospital Pharmacies
• 9.4. Retail Pharmacies
• 9.5. Specialty Clinics

10. Americas Dysphagia Management Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Dysphagia Management Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Dysphagia Management Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca PLC
• 3. Becton, Dickinson and Company
• 4. Bracco Diagnostics Inc.
• 5. Cipla Limited
• 6. Cook Group Incorporated
• 7. Danone S.A.
• 8. Deosen Biochemical (Ordos) Ltd.
• 9. Dr. Reddy's Laboratories Ltd.
• 10. Eisia Co.Ltd.
• 11. F. Hoffmann-La Roche AG
• 12. Flavour Creations
• 13. Fresenius Kabi AG
• 14. Hormel Foods Corporation
• 15. Ingredion Incorporated
• 16. International Flavors & Fragrances Inc.
• 17. Johnson & Johnson Services, Inc.
• 18. Kent Precision Foods Group, Inc.
• 19. Medline Industries, LP
• 20. Nestle S.A.
• 21. Novartis AG
• 22. Phagenesis Ltd.
• 23. Rosemont Pharmaceuticals Limited
• 24. Slo Drinks
• 25. VitalStim UK Ltd.